Luxi Chemical Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	29,836	29,497	25,194	30,203	31,592	17,473
Other Revenue	265.93	265.93	163.75	153.47	202.83	119.32
Revenue	30,102	29,763	25,358	30,357	31,794	17,592
Revenue Growth (YoY)	3.82%	17.37%	-16.47%	-4.52%	80.73%	-3.37%
Cost of Revenue	26,574	25,574	22,095	24,417	22,280	14,863
Gross Profit	3,528	4,189	3,263	5,940	9,514	2,729
Selling, General & Admin	605.93	633.13	642.16	634.82	513.37	462.24
Research & Development	811.7	960.28	932.66	990.28	1,041	580.29
Other Operating Expenses	53.25	98.44	119.42	202.43	260.86	142.76
Operating Expenses	1,472	1,692	1,686	1,830	1,903	1,184
Operating Income	2,056	2,497	1,577	4,110	7,611	1,545
Interest Expense	-194.13	-175.1	-259.16	-252.07	-453.78	-525.68
Interest & Investment Income	8.6	12.78	11.5	20.47	19.48	22.1
Currency Exchange Gain (Loss)	12.39	12.39	6.52	4.73	-4.32	-4.23
Other Non Operating Income (Expenses)	-40.57	-5.77	-10.46	-20.25	-5.24	-20.51
EBT Excluding Unusual Items	1,842	2,341	1,325	3,863	7,168	1,017
Gain (Loss) on Sale of Investments	-4.79	-	-	-	-	-
Gain (Loss) on Sale of Assets	99.81	32.37	-23.35	14.95	-54.58	-18.68
Asset Writedown	-338.11	-8.44	-282.71	-176.18	-368.62	-
Legal Settlements	1.24	1.24	-	-1.24	-833.57	-
Other Unusual Items	129.14	129.14	32.91	87.71	136.23	95.5
Pretax Income	1,736	2,502	1,053	3,788	6,047	1,094
Income Tax Expense	255.98	471.41	233.25	632.72	1,427	269.02
Earnings From Continuing Operations	1,480	2,031	819.79	3,156	4,620	824.97
Minority Interest in Earnings	-3.18	-2.18	-1.08	-0.34	-0.95	-0.14
Net Income	1,477	2,029	818.71	3,155	4,619	824.83
Net Income to Common	1,477	2,029	818.71	3,155	4,619	824.83
Net Income Growth	-21.71%	147.79%	-74.05%	-31.68%	459.95%	-52.22%
Shares Outstanding (Basic)	1,906	1,905	1,913	1,923	1,905	1,465
Shares Outstanding (Diluted)	1,906	1,905	1,913	1,923	1,905	1,465
Shares Change (YoY)	0.81%	-0.42%	-0.52%	0.96%	30.00%	-0.71%
EPS (Basic)	0.78	1.06	0.43	1.64	2.42	0.56
EPS (Diluted)	0.78	1.06	0.43	1.64	2.42	0.56
EPS Growth	-22.34%	148.83%	-73.92%	-32.33%	330.73%	-51.88%
Free Cash Flow	2,149	1,406	375.42	654.18	5,704	109.65
Free Cash Flow Per Share	1.13	0.74	0.20	0.34	3.00	0.07
Dividend Per Share	0.350	0.350	0.130	0.650	2.000	0.500
Dividend Growth	169.23%	169.23%	-80.00%	-67.50%	300.00%	-
Gross Margin	11.72%	14.07%	12.87%	19.57%	29.93%	15.51%
Operating Margin	6.83%	8.39%	6.22%	13.54%	23.94%	8.79%
Profit Margin	4.91%	6.82%	3.23%	10.39%	14.53%	4.69%
Free Cash Flow Margin	7.14%	4.72%	1.48%	2.15%	17.94%	0.62%
EBITDA	4,249	4,714	3,826	6,272	9,695	3,480
EBITDA Margin	14.12%	15.84%	15.09%	20.66%	30.49%	19.78%
D&A For EBITDA	2,193	2,217	2,249	2,162	2,083	1,935
EBIT	2,056	2,497	1,577	4,110	7,611	1,545
EBIT Margin	6.83%	8.39%	6.22%	13.54%	23.94%	8.79%
Effective Tax Rate	14.74%	18.84%	22.15%	16.70%	23.61%	24.59%
Revenue as Reported	30,102	29,763	25,358	30,357	31,794	17,592
Advertising Expenses	-	2.39	3.08	2.11	2.43	2.75

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.